glp-1 agonists and retained gastric contents at endoscopy Hold GLP-1s Before Endoscopy? Clinical Trial Finds SMALL STUDY LOOKS AT HOLDING
Description
Obesity is a growing epidemic that affects millions of people worldwide, leading to serious health complications such as heart disease, diabetes, and certain cancers
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
Your body depends on glucose for energy
They also offer the
